The relation between arterial blood pressure variables and ventricular repolarization parameters

International Journal of Collaborative Research on Internal Medicine and Public Health

Volumn 4, Issue 6, 2012, Pages 860-875

  Mozos, Ioana ^a   Serban, Corina ^a   Mihaescu, Rodica ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Hypertension; Pulse pressure; QT interval; Tpeak Tend interval

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMAL QT INTERVAL DURATION; MAXIMAL T WAVE AMPLITUDE; MAXIMAL T WAVE DURATION; MAXIMAL TPEAK TEND INTERVAL; MEAN ARTERIAL PRESSURE; MEAN QT INTERVAL DURATION; MULTIPLE REGRESSION; PREDICTION; PULSE PRESSURE; QT INTERVAL; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; T WAVE;

EID: 84862228334     PISSN: 18404529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Vaccarino V, Holford TR, Krumholz HM: Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol. 2000;36:130-138.
2. Yildirir A, Batur MK, Oto A: Hypertension and arrhythmia: blood pressure control and beyond. Europace. 2002;4:175-182.
3. Kaftan AH, Kaftan O: QT Intervals and Heart Rate Variability in Hypertensive Patients. Jpn Heart J. 2000;41:173-182.
4. Mozos I, Serban C: The relation between QT interval and T-wave variables in hypertensive patients. J Pharm Bioall Sci. 2011;3:339-344.
5. Palatini P, Maraglino G, Accurso V, et al. Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate. Br Heart J. 1995;73:258-262.
6. Kujanik S: Comparison and recalculation of the very different QTc interval durations in young healthy women. Acta Physiol Hung. 2011;98(3):262-272.
7. Postema PG, De Jong JSSG, Van der Bilt IAC, Wilde AAM: Accurate electrocardiographic assessment of the QT interval: Teach the tangent. Heart Rhythm. 2008;5:1015-1018.
8. Chan A, Isbister GK, Kirkpatrick CMJ, Dufful SB: Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. Q J Med. 2007; 100:609-615.
9. Sohaib SMA, Papacosta O, Morris RW, et al. Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol. 2008; 41:704-710.
10. Maule S, Rabbia F, Perni V, et al. Prolonged QT Interval and Reduced Heart Rate Variability in Patients with Uncomplicated Essential Hypertension. Hypertens Res. 2008; 31:2003-2010.
11. Tolga Dogru M, Guneri M, Tireli E, et al. QT interval and dispersion differences between normal and prehypertensive patients: effects of autonomic and left ventricular functional and structural changes. Anadolu Kardiyol Derg. 2009; 9:15-22.
12. Zabel M, Portnoy S, Franz MR: Electrocardiographic indices of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol. 1995;25:746-752.
13. Celi A: QT dispersion: Time for a revival? Intern Emerg Med. 2006;1:262-263.
14. Mozos I, Hancu M, Jost N, Cristescu A: Multipo lar QRST isointegral maps and QT dispersion in old myocardial infarction. Acta Physiol Hung. 2010;97:11-21.
15. Malik M, Batchvarov V: Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36:1749-1766.
16. Gussack I, Antzelevitch C: Electrical Diseases of the Heart. Genetics, Mechanisms, Treatment, Prevention. London: Springer Publishing House; 2008.
17. Kanters JK, Haarmark C, Vedel-Larsen E, et al. TpeakTend interval in long QT syndrome. J Electrocardiol. 2008;41:603-608.
18. Mancia G, De Baker G, Dominiczak A, et al. Guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462-1536.
19. nd Edition. Lippincott Williams & Wilkins; 2011.
20. El-Menyar A, Zubaid M, Almahmeed W, et al. Initial hospital pulse pressure and cardiovascular outcomes in acute coronary syndrome. Arch Cardiovasc Dis. 2011 Aug;104(8- 9):435-443.
21. Cecelja M, Jiang B, McNeill K, et al. Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions. A twin study. J Am Coll Cardiol. 2009;54:695-703.
22. Fagard RH, Pardaens K, Staessen JA, Thijs L: The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol. 2001;38:227-231.
23. Petrie CJ, Voors AA, van Veldhuisen DJ: Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients. Int J Cardiol. 2009; 131:336-344.
24. Peng S, Yu Y, Hao K, et al. Heart rate-corrected QT interval duration is significantly associated with blood pressure in Chinese hypertensives. J Electrocardiol. 2006; 39: 206-210.
25. Matsumura K, Takata Y, Ansai T, et al. Association of QT interval with blood pressure in 80-year-old subjects. Hypertens Research.2004; 27: 387-391
26. Cuspidi C, Vaccarella A, Negri F, Sala C: Resistant hypertension and left ventricular hypertrophy: an overwiew. J Am Soc Hypertens. 2010;4(6):319-324.
27. Batchvarov V, Malik M: Individual patterns of QT/RR relationship. Card Electrophysiol Rev. 2002;6:282-288.
28. Kumar R, Fisher M, Macfarlane PW: Diabetes and the QT interval: Time for debate. Br J Diabetes Vasc Dis. 2004;4:146-150.
29. Szabo Z, Harangi M, Lorincz I, et al. Effect of hyperlipidemia on QT dispersion in patients without ischemic heart disease. Can J Cardiol. 2005;21(10):847-850.
30. Andrassy G, Szabo A, Dunai A, et al. Acute effects of cigarette smoking on the QT interval in healthy smokers. Am J Cardiol. 2003;92(4):489-492.
31. Shimlizul W, Aiba T, Antzelevitch C: Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. Curr Pharm Des. 2005;11(12);1561-1572.
32. Zipes D, Camm J, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. Eur Heart J. 2006;27:2099-2140.
33. Lopez-Sendon J, Swedberg K, McMurray J et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004;25:1341-1362.
34. Michowitz MK, Michowitz Y, Zaidenstien R, Golik A: Drug-induced QT prolongation. IMAJ. 2000; 2:924-928.
35. Bennett MT, Gula LJ, Klein GJ, et al. Do beta-blockers affect non corrected QT interval in type 1 long QT syndrome? Circulation. 2009;120:S653.
36. Pala AM, Ricciardelli D, Sanna A, Vinattieri MA: The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block. Minerva Med. 1989;80(12):1283-1287.
37. Viitasalo M, Oikarinen L, Swan H, et al. Effects of beta-blocker therapy on ventricular repolarization documented by 24-h electrocardiography in patients with type 1 long-QT syndrome. J Am Coll Cardiol. 2006;48(4):747-753.
38. Dias da Silva VJ, Ferreira Neto E, Salgado HC, et al. Chronic converting enzyme inhibition normalizes QT interval in aging rats. Braz J Med Biol Res. 2002;35:1025-1031.
39. Funada A, Hayashi K, Ino H, et al. Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clin Cardiol. 2008;31:270-440.
40. Ruilope LM, Schmieder RE: Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21(5):500-508
41. Turrini P, Corrado D, Basso C, Nava A, Bauce B, Thiene G: Dispersion of Ventricular Depolarisation-Repolarisation. Circulation. 2001;103:3075-3080